Clinical Trial Update: Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial updating long-term safety and tolerability of desmopressin ODT for nocturia due to nocturnal polyuria in Japanese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED